Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between 18 and 65 years of age
- People classified as having a general health status of low-to-moderate anaesthetic risk (this is a standard pre-surgery health rating known as ASA class I, II, or III — confirm with trial site if unsure which category applies)
- People who are scheduled for a planned, non-emergency removal of one breast along with nearby lymph nodes, performed under general anaesthesia
- People who are able to understand and use a simple number scale (0–10) to rate their pain level
- People who have signed a written consent form agreeing to take part
Who may not be able to join:
- People with a known allergy or sensitivity to local anaesthetic medicines, such as bupivacaine
- People with blood clotting problems, a low platelet count, or who are taking blood-thinning or anti-clotting medications that cannot be safely stopped before the procedure
- People who have an infection or a skin problem at the area where the injection would be given
- People who are having surgery on both sides, or who have another major surgical procedure planned at the same time
- People who live with ongoing chronic pain, or who regularly use opioid painkillers, certain nerve pain medications (such as gabapentin or pregabalin), or other similar centrally acting pain medicines
- People with a neurological or mental health condition that would make it difficult to accurately report pain levels
- People who have previously had major surgery on the chest or chest wall on the same side as the planned operation
- People who are pregnant or breastfeeding
- People who do not wish to take part, or who are unable to give informed consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fatma Acil, M.D., Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Phone: +905337225225
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
24-hour cumulative opioid consumption
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.